Facebooktwittergoogle_pluslinkedinyoutubeinstagram

Home

Cohen Veterans Bioscience
Cohen Veterans Bioscience
Cohen Veterans Bioscience
RAPID-Dx Consensus Conference
CVB-initial-slide-600
CVB-pbs-slide-600

Advancing Brain Health

We are dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma to the brain.

PTSD

1 in 5 Veterans of the Iraq & Afghanistan wars have been diagnosed with PTSD.
8% of people have PTSD at some point during their lives.

TBI

There are 1.7 Million Traumatic Brain Injuries in the United States every year.
5.3 Million suffer from TBI-induced disabilities.

We Need Precision Medicine for The Brain

We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.

Recent Highlights

News

Events

  • 7th Annual Traumatic Brain Injury Conference – May 24-25, 2017 in Washington, D.C.
    7th Annual Traumatic Brain Injury Conference – May 24-25, 2017 in Washington, D.C.

    Cohen Veterans Bioscience CEO & President Dr. Magali Haas is participating in a panel discussion at the 7th Annual Traumatic Brain Injury Conference, May 24-25, 2017 in Washington, D.C.

    This conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury.

Webinars

  • The Treatment of PTSD and the Warrior Care Network
    The Treatment of PTSD and the Warrior Care Network

    In this webinar, Dr. Barbara Rothbaum, who leads the Emory Veterans Program, explores post-traumatic stress disorder (PTSD) and its treatment both in general and within the Warrior Care Network.